384 research outputs found
10. Putting the ‘Fun’ Back in ‘Funeral’
The Roman Emperor Marcus Aurelius writes in his notebooks: “You are a little soul carrying a corpse,” quoting the Greek stoic philosopher Epictetus. As he was likely writing these notes to himself as a form of mental discipline in the throes of a military campaign, he obviously meant that observation to be comforting. To most it is far from that, of course—but the reason why this is so is worthy of some attention. [excerpt
Generalized-Ensemble Simulations of the Human Parathyroid Hormone Fragment PTH(1-34)
A generalized-ensemble technique, multicanonical sampling, is used to study
the folding of a 34-residue human parathyroid hormone fragment. An all-atom
model of the peptide is employed and the protein-solvent interactions are
approximated by an implicit solvent. Our results demonstrate that
generalized-ensemble simulations are well suited to sample low-energy
structures of such large polypeptides. Configurations with a root-mean-square
deviation (rmsd) to the crystal structure of less than one \AA are found.
Finally, we discuss limitations of our implicit solvent model.Comment: To appear in J. Chem. Phy
Present status of renal replacement therapy at 2015 in Asian countries (Myanmar, Vietnam, Thailand, China, and Japan)
The effect of high intakes of casein and casein phosphopeptide on calcium absorption in the rat
peer-reviewedThe effect of the level or source of dietary protein or protein-derived peptides on Ca absorption is
not well understood. We determined, therefore, the influence of habitual dietary casein level,
meal casein and meal casein phosphopeptide (CPP) on Ca absorption in the rat. True fractional
Ca absorption was investigated in male 7-week-old rats, Wistar strain, in three separate studies
using a faecal 47Sc : 47Ca ratio method. In studies A and C, rats (n 8 per group) were fed on a
purified diet containing 200 g casein/kg for 2 weeks. Rats were then given a 47Ca-labelled meal
(10 g) containing (per kg) either 0, 100, 200, or 300 g casein (study A) or 0, 100, 200, 350 or 500 g
CPP (study C). In study B, rats (n 24 per group) were fed on a purified diet containing (per kg)
either 200, 350 or 500 g casein for 2 weeks. Each group was then further randomized into three
groups (n 8 per group) and given a 47Ca-labelled meal (10 g of the same diet) containing (per kg)
either 200, 350 or 500 g casein. Ca absorption from a meal was unaffected by increasing meal
casein concentration from 0 to 300 g/kg (study A), but was increased with a meal casein content
of 500 g/kg (study B). Fractional Ca absorption decreased with increasing usual dietary casein
intake in the range 200±500 g/kg (study B), suggesting intestinal adaptation. Ca absorption was
unaffected by inclusion of 100 g CPP/kg in a single meal but was significantly (P,0×001)
reduced by 200, 350 and 500 g CPP/kg meal, with no evident dose-relationship. Thus, while Ca
absorption was enhanced by high-casein meals, the mechanism remains unclear
Influence of Ovariectomy on Bone Turnover and Trabecular Bone Mass in Mature Cynomolgus Monkeys
Purpose: To examine the influence of ovariectomy (OVX) on bone turnover and trabecular bone mass at the 3 clinically important skeletal sites in mature cynomolgus monkeys. Materials and Methods: Six female cynomolgus monkeys, aged 17-21 years, were randomized into 2 groups by the stratified weight: the OVX and sham-operation groups (n = 3 in each group). The experimental period was 16 months. Lumbar bone mineral density (BMD) in vivo and serum and urinary bone turnover markers were longitudinally measured, and peripheral quantitative computed tomographic and bone histomorphometric analyses were performed on trabecular bone of the lumbar vertebra, femoral neck, and distal radius at the end of the experiment. Results: OVX induced in a reduction in lumbar BMD compared with the sham controls and the baseline, as a result of increased serum levels of bonespecific alkaline phosphatase and urinary levels of cross-lined N- and C-terminal telopeptides of type I collagen. Furthermore, OVX induced reductions in trabecular volumetric BMD and trabecular bone mass compared with the sham controls, with increased bone formation rate at the lumbar vertebra, femoral neck, and distal radius. Conclusion: The results indicated that OVX in mature cynomolgus monkeys (17-21 years of age) increased bone turnover and induced trabecular bone loss at the three skeletal sites compared with the sham controls. Thus, mature cynomolgus monkeys could be utilized for preclinical studies to examine the effects of interventions on bon
Recommended from our members
Prebiotic effects: metabolic and health benefits
The different compartments of the gastrointestinal tract are inhabited by populations of micro-organisms. By far the most important predominant populations are in the colon where a true symbiosis with the host exists that is a key for well-being and health. For such a microbiota, 'normobiosis' characterises a composition of the gut 'ecosystem' in which micro-organisms with potential health benefits predominate in number over potentially harmful ones, in contrast to 'dysbiosis', in which one or a few potentially harmful micro-organisms are dominant, thus creating a disease-prone situation. The present document has been written by a group of both academic and industry experts (in the ILSI Europe Prebiotic Expert Group and Prebiotic Task Force, respectively). It does not aim to propose a new definition of a prebiotic nor to identify which food products are classified as prebiotic but rather to validate and expand the original idea of the prebiotic concept (that can be translated in 'prebiotic effects'), defined as: 'The selective stimulation of growth and/or activity(ies) of one or a limited number of microbial genus(era)/species in the gut microbiota that confer(s) health benefits to the host.' Thanks to the methodological and fundamental research of microbiologists, immense progress has very recently been made in our understanding of the gut microbiota. A large number of human intervention studies have been performed that have demonstrated that dietary consumption of certain food products can result in statistically significant changes in the composition of the gut microbiota in line with the prebiotic concept. Thus the prebiotic effect is now a well-established scientific fact. The more data are accumulating, the more it will be recognised that such changes in the microbiota's composition, especially increase in bifidobacteria, can be regarded as a marker of intestinal health. The review is divided in chapters that cover the major areas of nutrition research where a prebiotic effect has tentatively been investigated for potential health benefits. The prebiotic effect has been shown to associate with modulation of biomarkers and activity(ies) of the immune system. Confirming the studies in adults, it has been demonstrated that, in infant nutrition, the prebiotic effect includes a significant change of gut microbiota composition, especially an increase of faecal concentrations of bifidobacteria. This concomitantly improves stool quality (pH, SCFA, frequency and consistency), reduces the risk of gastroenteritis and infections, improves general well-being and reduces the incidence of allergic symptoms such as atopic eczema. Changes in the gut microbiota composition are classically considered as one of the many factors involved in the pathogenesis of either inflammatory bowel disease or irritable bowel syndrome. The use of particular food products with a prebiotic effect has thus been tested in clinical trials with the objective to improve the clinical activity and well-being of patients with such disorders. Promising beneficial effects have been demonstrated in some preliminary studies, including changes in gut microbiota composition (especially increase in bifidobacteria concentration). Often associated with toxic load and/or miscellaneous risk factors, colon cancer is another pathology for which a possible role of gut microbiota composition has been hypothesised. Numerous experimental studies have reported reduction in incidence of tumours and cancers after feeding specific food products with a prebiotic effect. Some of these studies (including one human trial) have also reported that, in such conditions, gut microbiota composition was modified (especially due to increased concentration of bifidobacteria). Dietary intake of particular food products with a prebiotic effect has been shown, especially in adolescents, but also tentatively in postmenopausal women, to increase Ca absorption as well as bone Ca accretion and bone mineral density. Recent data, both from experimental models and from human studies, support the beneficial effects of particular food products with prebiotic properties on energy homaeostasis, satiety regulation and body weight gain. Together, with data in obese animals and patients, these studies support the hypothesis that gut microbiota composition (especially the number of bifidobacteria) may contribute to modulate metabolic processes associated with syndrome X, especially obesity and diabetes type 2. It is plausible, even though not exclusive, that these effects are linked to the microbiota-induced changes and it is feasible to conclude that their mechanisms fit into the prebiotic effect. However, the role of such changes in these health benefits remains to be definitively proven. As a result of the research activity that followed the publication of the prebiotic concept 15 years ago, it has become clear that products that cause a selective modification in the gut microbiota's composition and/or activity(ies) and thus strengthens normobiosis could either induce beneficial physiological effects in the colon and also in extra-intestinal compartments or contribute towards reducing the risk of dysbiosis and associated intestinal and systemic pathologies
Standardized, systemic phenotypic analysis reveals kidney dysfunction as main alteration of Kctd1 I27N mutant mice
Background: Increased levels of blood plasma urea were used as phenotypic parameter for establishing novel mouse models for kidney diseases on the genetic background of C3H inbred mice in the phenotype-driven Munich ENU mouse mutagenesis project. The phenotypically dominant mutant line HST014 was established and further analyzed. Methods: Analysis of the causative mutation as well as the standardized, systemic phenotypic analysis of the mutant line was carried out. Results: The causative mutation was detected in the potassium channel tetramerization domain containing 1 (Kctd1) gene which leads to the amino acid exchange Kctd1 I27N thereby affecting the functional BTB domain of the protein. This line is the first mouse model harboring a Kctd1 mutation. Kctd1 I27N homozygous mutant mice die perinatally. Standardized, systemic phenotypic analysis of Kctd1 I27N heterozygous mutants was carried out in the German Mouse Clinic (GMC). Systematic morphological investigation of the external physical appearance did not detect the specific alterations that are described in KCTD1 mutant human patients affected by the scalp-ear-nipple (SEN) syndrome. The main pathological phenotype of the Kctd1 I27N heterozygous mutant mice consists of kidney dysfunction and secondary effects thereof, without gross additional primary alterations in the other phenotypic parameters analyzed. Genome-wide transcriptome profiling analysis at the age of 4 months revealed about 100 differentially expressed genes (DEGs) in kidneys of Kctd1 I27N heterozygous mutants as compared to wild-type controls. Conclusions: In summary, the main alteration of the Kctd1 I27N heterozygous mutants consists in kidney dysfunction. Additional analyses in 9–21 week-old heterozygous mutants revealed only few minor effects
Cortical-Bone Fragility - Insights from sFRP4 Deficiency in Pyle's Disease
BACKGROUND
Cortical-bone fragility is a common feature in osteoporosis that is linked to non
-
vertebral fractures. Regulation of cortical-bone homeostasis has proved elusive. The
study of genetic disorders of the skeleton can yield insights that fuel experimental
therapeutic approaches to the treatment of rare disorders and common skeletal
ailments.
METHODS
We evaluated four patients with Pyle’s disease, a genetic disorder that is characterized
by cortical-bone thinning, limb deformity, and fractures; two patients were examined
by means of exome sequencing, and two were examined by means of Sanger se
-
quencing. After a candidate gene was identified, we generated a knockout mouse
model that manifested the phenotype and studied the mechanisms responsible for
altered bone architecture.
RESULTS
In all affected patients, we found biallelic truncating mutations in
SFR P4
, the gene
encoding secreted frizzled-related protein 4, a soluble Wnt inhibitor. Mice deficient
in
Sfrp4
, like persons with Pyle’s disease, have increased amounts of trabecular bone
and unusually thin cortical bone, as a result of differential regulation of Wnt and
bone morphogenetic protein (BMP) signaling in these two bone compartments. Treat
-
ment of
Sfrp4-
deficient mice with a soluble Bmp2 receptor (RAP-661) or with anti
-
bodies to sclerostin corrected the cortical-bone defect.
CONCLUSIONS
Our study showed that Pyle’s disease was caused by a deficiency of sFRP4, that cortical-
bone and trabecular-bone homeostasis were governed by different mechanisms, and
that sFRP4-mediated cross-regulation between Wnt and BMP signaling was critical
for achieving proper cortical-bone thickness and stability. (Funded by the Swiss Na
-
tional Foundation and the National Institutes of Health.
A large scale hearing loss screen reveals an extensive unexplored genetic landscape for auditory dysfunction
The developmental and physiological complexity of the auditory system is likely reflected in the underlying set of genes involved in auditory function. In humans, over 150 non-syndromic loci have been identified, and there are more than 400 human genetic syndromes with a hearing loss component. Over 100 non-syndromic hearing loss genes have been identified in mouse and human, but we remain ignorant of the full extent of the genetic landscape involved in auditory dysfunction. As part of the International Mouse Phenotyping Consortium, we undertook a hearing loss screen in a cohort of 3006 mouse knockout strains. In total, we identify 67 candidate hearing loss genes. We detect known hearing loss genes, but the vast majority, 52, of the candidate genes were novel. Our analysis reveals a large and unexplored genetic landscape involved with auditory function
- …